+31 (0) 71 332 2866
Predicting Treatment Outcome
VitroScan is a Dutch biotech company dedicated to deliver predictive diagnostic tests to improve the selection of drug treatment for cancer patients.
About us

Personalized Medicine

Improving the selection of drug treatment for individual cancer patients is of high importance. Increasing numbers of treatments options in the clinic, and fast expanding numbers of new drugs in clinical development urge implementation of novel technologies. 

VitroScans’ best-in-class technology is based on testing drug sensitivity on ex vivo 3D tumor cultures from patients. Our Drug Response Platform is proven effective for identification and testing (new) drugs for cancer treatment, it is scalable, and very suitable for accurate testing of large number of patients’ samples.

Latest news

Drug Response Platform
learn more...
Contact us